MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, D. R.
Right arrow Articles by Sreedharan, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, D. R.
Right arrow Articles by Sreedharan, S. P.

Molecular cloning and expression of a human secretin receptor

DR Patel, Y Kong and SP Sreedharan

Department of Medicine, University of California School of Medicine, San Francisco 94143.

Secretin is a 27-amino acid neuroendocrine peptide that stimulates fluid and electrolyte secretion in the gastrointestinal tract, activates tyrosine hydroxylase activity in the central nervous system, and affects cardiac and renal function. Specific receptors for secretin have been previously characterized on neuroblastoma cells, pancreatic acini, gastric glands, and liver cholangiocytes. We report here the isolation of a 1616-base pair cDNA from human lung tissue that encodes a 440-amino acid, 50-kDa, G protein-coupled human secretin receptor (HSR), with homology of 80% with the rat secretin receptor and 37% with the human type I vasoactive intestinal peptide receptor. Northern blot analysis of human tissue mRNA revealed that the relative intensity for expression of a 2.1-kilobase HSR transcript was pancreas > kidney > small intestine > lung > liver, with trace levels in brain, heart, and ovary. Stable transfectants of HSR in human embryonic kidney 293 cells, termed 293S12, expressed 10(5) binding sites/cell for 125I-secretin, with an apparent Kd of 3.2 nM. Vasoactive intestinal peptide, pituitary adenylyl cyclase-activating peptide-38, and glucagon were less potent (by 3 orders of magnitude) than secretin in competitively inhibiting 125I-secretin binding to 293S12 cells. Secretin evoked concurrent dose- dependent increases in intracellular cAMP and calcium levels in 293S12 cells and stimulated a 4-fold increase in phosphatidylinositol hydrolysis. Thus, the HSR expressed by stable transfectants can couple to two distinct intracellular signaling pathways.

Volume 47, Issue 3, pp. 467-473, 03/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. Korner, G. M. Hayes, R. Rehmann, A. Zimmermann, H. Friess, L. J. Miller, and J. C. Reubi
Secretin Receptors in Normal and Diseased Human Pancreas: Marked Reduction of Receptor Binding in Ductal Neoplasia
Am. J. Pathol., October 1, 2005; 167(4): 959 - 968.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. J. Davis, K. J. Page, G. J. Dos Santos Cruz, D. W. Harmer, P. W. Munday, S. J. Williams, J. Picot, T. J. Evans, R. L. Sheldrick, R. A. Coleman, et al.
Expression and Functions of the Duodenal Peptide Secretin and its Receptor in Human Lung
Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 302 - 308.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. T.-K. Pang, L. T.-O. Lee, S. S.-M. Ng, W.-H. Yung, and B. K.-C. Chow
CpG Methylation and Transcription Factors Sp1 and Sp3 Regulate the Expression of the Human Secretin Receptor Gene
Mol. Endocrinol., February 1, 2004; 18(2): 471 - 483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. C. Chen, T. E. Solomon, E. P. Salazar, R. Kui, E. Rozengurt, and A. H. Soll
Secretin regulates paracellular permeability in canine gastric monolayers by a Src kinase-dependent pathway
Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G893 - G899.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Y.-Y. Chan, R. T.-K. Pang, and B. K.-C. Chow
Functional Segregation of the Highly Conserved Basic Motifs within the Third Endoloop of the Human Secretin Receptor
Endocrinology, September 1, 2001; 142(9): 3926 - 3934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. E. Solomon, G. Varga, N. Zeng, S. V. Wu, J. H. Walsh, and J. R. Reeve Jr.
Different actions of secretin and Gly-extended secretin predict secretin receptor subtypes
Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G88 - G94.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. M. Sherwood, S. L. Krueckl, and J. E. McRory
The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon Superfamily
Endocr. Rev., December 1, 2000; 21(6): 619 - 670.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. T.-K. Pang, S. S.-M. Ng, C. H.-K. Cheng, M. H. Holtmann, L. J. Miller, and B. K.-C. Chow
Role of N-Linked Glycosylation on the Function and Expression of the Human Secretin Receptor
Endocrinology, November 1, 1999; 140(11): 5102 - 5111.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics